반응형

 

구분 보고서(영문)
제약/바이오/
임상시험
(3건)		 Bio/Pharmaceutical Outsourcing Report, August 2024
Migraine Market Expected to Reach $16.4 Billion Across 7MM by 2033
Emerging Microbiome Market—Unlocking New Frontiers
컨퍼런스/
심포지엄/
학회/기타
(17건)		 ESC 2024: Obicetrapib - A Promising Breakthrough for Dyslipidemia Treatment
ESC 2024: SELECT Trial Provides Promising Results for the Treatment of Obesity-Related HFpEF with Semaglutide 2.4mg
ESC 2024: Additional Analysis of FLOW Trial Highlights That CKD Patients Could Positively Benefit From Ozempic
ESC 2024: Retatrutide Improves Lipid and Cardiovascular Risk Profile in Phase II Trial
ESC 2024: Study Highlights Novartis’ Potential to Differentiate in HF Space
ESC 2024: Sacubitril/Valsartan Continues to Impress in HF
ESC 2024: FINEARTS-HF Trial Sheds Positive Light on Kerendia for HFmrEF/HFpEF
ESC 2024: Results From CATHEDRAL-HF Trial Has the Potential to Reduce Polypharmacy
ESC 2024: GLP-1RAs Lower Cardiovascular Risk in Meta-Analysis of 32,884 Patients
EASD 2024: Survodutide Shows Promise in Overweight, Obesity, and MASH
EASD 2024: Novel Insights into Maternal Protection in Type 1 Diabetes
EASD 2024: Bayer’s Kerendia Continues to Impress with Pooled Analysis
EASD 2024: Cardiovascular and Inflammatory Markers Decrease after Treatment with Oral GLP-1R Agonist Orforglipron
EASD 2024: Mazdutide Improves Cardiometabolic Function in Patients with Obesity or Overweight
EASD 2024: New Developments in Presymptomatic Type 1 Diabetes Screening
EASD 2024: Are Tetra-Agonists the Future of Metabolic Diseases Treatment?
EASD 2024: A COMBINEd Approach for Better Diabetes Management
질환별
(5건)		 NICE Approves New Osteoporosis Treatment for High-Risk Patients in the UK
Sickle Cell in September: Spreading Awareness and Supporting Solutions
Rising ADHD Diagnoses in 7MM Linked to Standardized Screening Tools and Guidelines
Uterine Leiomyoma: Competitive Landscape 
Dysmenorrhea: Competitive Landscape
반응형
저작자표시

'의료기기관련기관 > 국가임상시험지원재단' 카테고리의 다른 글

해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 8.30. (금)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 8.14. (수)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 7.5. (금)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 6.20. (목)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 6.3. (수)  (0) 2024.09.15
반응형

 

구분 보고서(영문)
제약/바이오/
임상시험(6건)		 Self-Sampling for HPV Improves Screening Rates in Non-attendees by 12%
Scholar Rock’s Apitegromab Shows Promise for Non-Ambulatory SMA Patients
Top 20 Biopharmas’ Market Cap Up 4.3% in Q2 2024 as GLP-1 Drug Innovators Hold Top Spots
Shortages Improve for Lilly’s GLP-1 Weight Loss Drugs, Bumping Sales Forecast by $3 Billion
Colombia’s President Signs Law to Strengthen Pharmaceutical Sector
Licensing agreements for innovator GLP1R drugs weigh in with over $6.2 billion in 2024
컨퍼런스/
심포지엄/
학회/기타
(3건)		 England and Wales Disparity in Pregnant Women’s COVID-19 and Influenza Vaccine Uptake
Nationwide Danish Atrial Fibrillation Study Finds Diminishing Sex Differences in Stroke Outcomes
Discrepancies Among Guidelines for Opioid Use in Chronic Pain Could Compound Addiction
질환별
(8건)		 Migraine: Seven-Market Drug Forecast and Market Analysis
Acute Coronary Syndrome: Competitive Landscape
Global Mpox Emergency Raises Questions on How to Avoid Another UK Outbreak
Epstein-Barr Virus: Competitive Landscape
Focal Segmental Glomerulosclerosis: Competitive Landscape
Celiac Disease: Competitive Landscape
First Real-World Data for rVSV-ZEBOV Vaccine Supports Use for Future Ebola Outbreaks
Chronic Obstructive Pulmonary Disease (COPD): Epidemiology Forecast to 2033
반응형
저작자표시

'의료기기관련기관 > 국가임상시험지원재단' 카테고리의 다른 글

해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 9.13. (금)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 8.14. (수)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 7.5. (금)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 6.20. (목)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 6.3. (수)  (0) 2024.09.15
반응형

 

구분 보고서(영문)
제약/바이오/
임상
시험(7건)		 Bio/Pharmaceutical Outsourcing Report, July 2024
Revenue Growth for 13 of Top 20 Biopharma Companies With Obesity Drug Successes in 2023
Casgevy: Launch Sequence and Price Analysis of the First Marketed CRISPR Therapy
Pfizer’s Hemophilia A Gene Therapy Shows Promise, but Tough Rivals Ahead
FINEARTS-HF Trial Highlights Kerendia’s Potential to Differentiate in HF Space
Adaptimmune Poised to Be a Market Leader in Soft Tissue Sarcoma Treatment with First TCR Approval
Madrigal Plans to Solidify Rezdiffra’s Position in MASH Despite Start Being Slower Than Expected
컨퍼런스/심포지엄/
학회/기타
(5건)		 Global Risk Report (Quarterly Update) Q2 2024
Contract Service Agreements – July 2024
July Quarterly Contract Manufacturing Mergers, Acquisitions, and Financing – Q2 2024
Contract Manufacturing: Opportunities and Threats – July 2024
M&A in the Contract Manufacturing Industry: Implications and Outlook - 2024 Edition
질환별
(5건)		 Recent Drug Approvals for Atopic Dermatitis to Contribute to Treatment Management
Attention Deficit Hyperactivity Disorder (ADHD): Opportunity Assessment and Forecast
Study Shows Insurance Instability Among Opioid Use Disorder Patients
Chronic Urticaria: Competitive Landscape
Spinal Muscular Atrophy: From Genes to Global Awareness
반응형
저작자표시

'의료기기관련기관 > 국가임상시험지원재단' 카테고리의 다른 글

해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 9.13. (금)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 8.30. (금)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 7.5. (금)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 6.20. (목)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 6.3. (수)  (0) 2024.09.15
반응형
구분 보고서(영문)
제약/바이오/
임상시험
(7건)		 Are Clinical Trial Sites Unfairly Bearing the Brunt of Trial Failures?
The FDA Awarded a Record Number of Review Designations to mRNA Vaccines in 2023
Capvaxive Will Enhance Protection Against Pneumococcal Disease in Older Adults
FDA Approval of Verona’s Ohtuvayre to Transform the US COPD Market for Exacerbators
North America Leads in Psychedelic Therapy Trials
CAR-T Landscape Set to Increase for 2024
FDA Approves Eli Lilly’s Kisunla (Donanemab) for Early Alzheimer’s Disease
컨퍼런스/
심포지엄/
학회/기타
(14건)		 May Quarterly Contract Manufacturing Mergers, Acquisitions, and Financing – Q2 2024
Blockbuster Deals Are Shaping Key Player CMOs Despite 31% Drop in M&A
Contract Manufacturing: Opportunities and Threats – May 2024
Gay and Bisexual Men Have a Significantly Higher Risk of Anxiety and Depression
Contract Service Agreements – May 2024
CAR T-Cells in Lupus: Promising Results at EULAR 2024 and Emergence of China
Heatwave Increases Risk of Serious Cardiovascular Health Problems
UK’s Antibiotic Subscription Funding Model—a Route to Market Sustainability?
EAN 2024: Anti-CGRPs More Effective Than Onabotulinumtoxin A in Chronic Migraine Prevention in Real-World
EAN 2024: Additional Analyses of Pridopidine Healey ALS Platform Trial Encouraging for Phase III Plans
EAN 2024: VNS and cenobamate – a new therapeutic alliance for drug-resistant epilepsy?
EAN 2024: Treatment Cessation and Re-initiation Can Reduce Benefits of Ajovy
EAN 2024: Benefits of Early Migraine Treatment Clear, but Implementation Remains Challenging
EAN 2024: Sublingual Apomorphine Better Tolerated by Dopamine Agonist Users
질환별
(11건)		 Chronic Kidney Disease: Seven -Market Drug Forecast and Market Analysis
Osteoporosis: Seven-Market Drug Forecast and Market Analysis
Impact and Implications of the $35 Monthly Price Cap on Asthma Inhalers
Prurigo Nodularis: Competitive Landscape
Female Infertility: Seven -Market Drug Forecast and Market Analysis
Soft Tissue Sarcoma: Competitive Landscape
Female Infertility: 68-Market Drug Analysis and Sales Forecast
Tay-Sachs Disease: Competitive Landscape
Presbyopia: Competitive Landscape
Primary Sclerosing Cholangitis: Competitive Landscape
Pharmaceutical Companies Are Shaping a Competitive Pipeline Landscape for Bronchiectasis
반응형
저작자표시

'의료기기관련기관 > 국가임상시험지원재단' 카테고리의 다른 글

해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 8.30. (금)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 8.14. (수)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 6.20. (목)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 6.3. (수)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 5.24. (금)  (0) 2024.09.15

+ Recent posts

티스토리툴바